IEQ Capital’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
Other funds holding LAB
LFCM
IEQ Capital's LAB Position: Q3 2026 in Review
IEQ Capital sold out of Standard BioTools (LAB) in Q3 2026, closing a stake of 199,864 shares — an estimated $164K sold.
IEQ Capital first reported a position in LAB in Q1 2025 and held it in 6 quarters. The position peaked at $164K in Q2 2026. 104 funds tracked by Wall St. Rank hold LAB as of Q3 2026.
- IEQ Capital reported no remaining Standard BioTools position as of Q3 2026 after selling out during the quarter.
- IEQ Capital sold 199,864 Standard BioTools shares in Q3 2026, an estimated $164K.
- IEQ Capital first reported a position in Standard BioTools in Q1 2025 and held it in 6 quarters.
- IEQ Capital's Standard BioTools position peaked at $164K in Q2 2026.
- 104 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2026.
Based on IEQ Capital's 13F filing for Q3 2026, filed 10 Nov 2026.